Cargando…

Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease?

BACKGROUND: Infants with critical congenital heart disease (CCHD) are more likely to be small for gestational age (SGA) or born to mothers with maternal placental syndrome. The objective of this study was to investigate the relationship between maternal placental syndrome, SGA, and gestational age (...

Descripción completa

Detalles Bibliográficos
Autores principales: Steurer, Martina A., Peyvandi, Shabnam, Baer, Rebecca J., Oltman, Scott P., Chambers, Christina D., Norton, Mary E., Ryckman, Kelli K., Moon‐Grady, Anita J., Keller, Roberta L., Shiboski, Stephen C., Jelliffe‐Pawlowski, Laura L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915289/
https://www.ncbi.nlm.nih.gov/pubmed/31726960
http://dx.doi.org/10.1161/JAHA.119.013194
_version_ 1783479981484015616
author Steurer, Martina A.
Peyvandi, Shabnam
Baer, Rebecca J.
Oltman, Scott P.
Chambers, Christina D.
Norton, Mary E.
Ryckman, Kelli K.
Moon‐Grady, Anita J.
Keller, Roberta L.
Shiboski, Stephen C.
Jelliffe‐Pawlowski, Laura L.
author_facet Steurer, Martina A.
Peyvandi, Shabnam
Baer, Rebecca J.
Oltman, Scott P.
Chambers, Christina D.
Norton, Mary E.
Ryckman, Kelli K.
Moon‐Grady, Anita J.
Keller, Roberta L.
Shiboski, Stephen C.
Jelliffe‐Pawlowski, Laura L.
author_sort Steurer, Martina A.
collection PubMed
description BACKGROUND: Infants with critical congenital heart disease (CCHD) are more likely to be small for gestational age (SGA) or born to mothers with maternal placental syndrome. The objective of this study was to investigate the relationship between maternal placental syndrome, SGA, and gestational age (GA) on 1‐year mortality in infants with CCHD. METHODS AND RESULTS: In a population‐based administrative database of all live‐born infants in California (2007–2012) we identified all infants with CCHD without chromosomal anomalies. Our primary predictor was an impaired fetal environment (IFE), defined as presence of maternal placental syndrome or SGA. We calculated hazard ratios to quantify the association between different components of IFE and 1‐year mortality and conducted a causal mediation analysis to assess GA at birth as a mediator. We identified 6863 infants with CCHD. IFE was present in 25.1%. Infants with IFE were more likely to die than infants without IFE (16.6% versus 11.1%; hazard ratios 1.55, 95% CI 1.34–1.78). Only SGA (hazard ratios 1.76, 95% CI 1.50–2.05) and placental abruption (hazard ratios 1.70, 95% CI 1.17–2.48) were significantly associated with mortality; preeclampsia and gestational hypertension had no significant association with mortality. The mediation analysis showed that 32.8% (95% CI 24.9–47.0%) of the relationship between IFE and mortality is mediated through GA. CONCLUSIONS: IFE is a significant contributor to outcomes in the CCHD population. SGA and placental abruption are the main drivers of postnatal mortality while other maternal placental syndrome components had much less of an impact. Only one third of the effect between IFE and mortality is mediated through GA.
format Online
Article
Text
id pubmed-6915289
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69152892019-12-23 Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease? Steurer, Martina A. Peyvandi, Shabnam Baer, Rebecca J. Oltman, Scott P. Chambers, Christina D. Norton, Mary E. Ryckman, Kelli K. Moon‐Grady, Anita J. Keller, Roberta L. Shiboski, Stephen C. Jelliffe‐Pawlowski, Laura L. J Am Heart Assoc Original Research BACKGROUND: Infants with critical congenital heart disease (CCHD) are more likely to be small for gestational age (SGA) or born to mothers with maternal placental syndrome. The objective of this study was to investigate the relationship between maternal placental syndrome, SGA, and gestational age (GA) on 1‐year mortality in infants with CCHD. METHODS AND RESULTS: In a population‐based administrative database of all live‐born infants in California (2007–2012) we identified all infants with CCHD without chromosomal anomalies. Our primary predictor was an impaired fetal environment (IFE), defined as presence of maternal placental syndrome or SGA. We calculated hazard ratios to quantify the association between different components of IFE and 1‐year mortality and conducted a causal mediation analysis to assess GA at birth as a mediator. We identified 6863 infants with CCHD. IFE was present in 25.1%. Infants with IFE were more likely to die than infants without IFE (16.6% versus 11.1%; hazard ratios 1.55, 95% CI 1.34–1.78). Only SGA (hazard ratios 1.76, 95% CI 1.50–2.05) and placental abruption (hazard ratios 1.70, 95% CI 1.17–2.48) were significantly associated with mortality; preeclampsia and gestational hypertension had no significant association with mortality. The mediation analysis showed that 32.8% (95% CI 24.9–47.0%) of the relationship between IFE and mortality is mediated through GA. CONCLUSIONS: IFE is a significant contributor to outcomes in the CCHD population. SGA and placental abruption are the main drivers of postnatal mortality while other maternal placental syndrome components had much less of an impact. Only one third of the effect between IFE and mortality is mediated through GA. John Wiley and Sons Inc. 2019-11-15 /pmc/articles/PMC6915289/ /pubmed/31726960 http://dx.doi.org/10.1161/JAHA.119.013194 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Steurer, Martina A.
Peyvandi, Shabnam
Baer, Rebecca J.
Oltman, Scott P.
Chambers, Christina D.
Norton, Mary E.
Ryckman, Kelli K.
Moon‐Grady, Anita J.
Keller, Roberta L.
Shiboski, Stephen C.
Jelliffe‐Pawlowski, Laura L.
Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease?
title Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease?
title_full Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease?
title_fullStr Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease?
title_full_unstemmed Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease?
title_short Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease?
title_sort impaired fetal environment and gestational age: what is driving mortality in neonates with critical congenital heart disease?
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915289/
https://www.ncbi.nlm.nih.gov/pubmed/31726960
http://dx.doi.org/10.1161/JAHA.119.013194
work_keys_str_mv AT steurermartinaa impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease
AT peyvandishabnam impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease
AT baerrebeccaj impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease
AT oltmanscottp impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease
AT chamberschristinad impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease
AT nortonmarye impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease
AT ryckmankellik impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease
AT moongradyanitaj impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease
AT kellerrobertal impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease
AT shiboskistephenc impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease
AT jelliffepawlowskilaural impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease